CDAKQ — Codiak BioSciences,. Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.06m
- -$26.01m
- $22.94m
Annual balance sheet for Codiak BioSciences,., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 127 | 88.9 | 83.4 | 88.9 | 76.9 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 128 | 91.1 | 94.1 | 93.8 | 90.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.9 | 5.91 | 17.6 | 53.4 | 45.4 |
Other Long Term Assets | |||||
Total Assets | 134 | 97.7 | 116 | 151 | 172 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.89 | 4.89 | 19.8 | 17.7 | 27.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.93 | 5.63 | 94 | 137 | 118 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 129 | 92 | 22 | 14.6 | 53.5 |
Total Liabilities & Shareholders' Equity | 134 | 97.7 | 116 | 151 | 172 |
Total Common Shares Outstanding |